
ã¢ã€ããå·ä¿å¥å§å¡äŒãå šç±³ã§åããŠCDCãšFDAã«åæãCOVIDã¯ã¯ãã³ã蚺çæããæ€å»
å èšäºã¯ãã¡ããã/Click here to read the original article.
ã¢ã€ããå·ãµãŠã¹ãŠã§ã¹ãå°åºä¿å¥æã¯ãå é±çäºäŒã4察3ã§COVID-19ã¯ã¯ãã³ã®æäŸãäžæ¢ããããšã決å®ããã
ã¢ã€ããå·ãµãŠã¹ãŠãšã¹ãå°åºä¿å¥æã¯ãå é±çäºäŒã4察3ã§COVID-19ã¯ã¯ãã³ã®æäŸãäžæ¢ããããšã決å®ããã
10æ22æ¥ã®æç¥šã«åºåžããã¢ã€ããå·å西éšã®äœæ°ã§çè·å©Šã®ããŒã©ã»ããã¬ã€ã¯ãããã£ãã§ã³ããŒãçŽã«ããèªã£ãã
Health Freedom Idahoã®ãšã°ãŒã¯ãã£ãã»ãã£ã¬ã¯ã¿ãŒã§ããMiste Karlfeldtæ°ã¯ãçäºäŒã®æ¡æ±ºãæŽå²çãªãã®ã§ããããšã«åæããããã¹ãªã«æºç¹ã§ãããšåœŒå¥³ã¯The DefenderçŽã«èªã£ãã
çäºäŒã®æ¡æ±ºã¯ã6ã€ã®é¡ã«ãŸãããåå°åºã«äºé²æ³šå°ã®æšé²ãæ¢ããããæ±ããçŽ300ã®ãããªãã¯ã»ã³ã¡ã³ããåãåã£ãåŸã«è¡ãããã
çäºäŒã¯æç¥šçŽåã«ãå¿èå°éå»ã®ããŒã¿ãŒã»ããã«ããŒå士ãç çåŠè ã®ã©ã€ã¢ã³ã»ã³ãŒã«å士ãå°å ç§å»ã®ã¬ããŒã¿ã»ã ãŒã³å士ãç£å©Šäººç§å»ã®ãžã§ãŒã ã¹ã»ãœãŒãå士ãããCOVID-19ã¯ã¯ãã³ã«é¢ããå®å šæ§ã®æžå¿µã«ã€ããŠã®ãã¬ãŒã³ããŒã·ã§ã³ãèããã
çäºäŒå¯äžã®å»åž«ã§ãããžã§ã³ã»ããªãã«å士ã圌ããè¬æŒã«æããã
ãããªãã«å士ã¯ãCOVID泚å°ã®å®³ãçç¥ããŠããéåžžã«åæ¢ãªçäºã§ãããã圌ã¯ç§ã«çºè¡šè ãéããæäŒããããããé Œãã ã®ã§ãã
COVID-19ã¯ã¯ãã³ã§è² å·ããå€ãã®äººã ãç¥ã£ãŠãããšããããã¬ã€ãšä»ã®äººã ã¯ãCOVID-19ã¯ã¯ãã³ã®å®³ã«é¢ããããŒã¿ãçäºäŒã«æç€ºã§ããå°éå®¶ã«é£çµ¡ãåã£ãããå®å šãªããŒã ã¯ãŒã¯ã§ãã
Children's Health Defenseã®CEOã§ããã¡ã¢ãªãŒã»ãã©ã³ãã¯ãçäºäŒã®è¡åãç§°è³ããïŒ
ã300äººã®ææš©è ãã話ãèããååãªæ å ±ãæã€å»åž«ã®è©±ãèããå ¬çèšé²ãè©äŸ¡ããçµæãå西ã¢ã€ããä¿å¥å°åºçäºäŒã¯ãèªåãã¡ã®ã¯ãªããã¯ã«COVID泚å°ãåšåº«ããªãããšããååãªæ å ±ãåŸãäžã§æ±ºå®ããã
ããã¬ã€ãšãã©ã³ãã¯ãçäºäŒãCOVID-19ã¯ã¯ãã³ãæ¥çš®ããèªç±ã奪ã£ãããã§ã¯ãªããšææããããäœæ°ãæããªããä»ã®è¬å±ãå»é¢ã§äºé²æ³šå°ãåããããšãã§ããŸãããšãã©ã³ãæ°ã¯è¿°ã¹ãã
ããã¬ã€ã¯ãçäºäŒã®æ±ºå®ã¯ ããã®äºé²æ³šå°ã«äžä¿¡æããã ãããšã瀺ããŠãããšè¿°ã¹ãã圌女ã¯ããä»ãå ããïŒ
ãä¿å¥æãèªåãã¡ã®èšºçæã§äºé²æ³šå°ãæã€ãšããããšã¯ããã®äºé²æ³šå°ãä¿¡ããŠãããšããããšã§ããã誰ããå·ã€ããšã¯æã£ãŠããªããšããããšã§ããé»èªããŠãããšããããšã§ããã
ä¿å¥æçäºäŒã¯ãããããã®è£œåã¯å®å šã§ã¯ãªãã®ã§æšé²ããªã ããšãã䟡å€èгãåžæ°ã«äŒããŠããã®ã§ãããçäºäŒã¯ãã®æš©éã®ç¯å²å ã«ããã
ä»ã®å»çæ©é¢ã®åäŸã«ãªããïŒ
ããªãã«ã¯ãDefenderãçŽã«ãæŽå²çãªæç¥šã«è³ããŸã§ã®çµç·¯ãèªã£ããããã®å°åºã®äººã ã¯çããæ±ããŠããŸãããããã®å°åºã®äœæ°ã¯çããæ±ããŠããã
äœæ°ã®å£°ã«è³ãåŸããåŸãçäºäŒã®ã¡ã³ããŒã¯ããCOVID-19ã¯ã¯ãã³ã®å®å šæ§ãšæå¹æ§ã«å¯Ÿããè³åŠäž¡è«ã®èšŒæ ã«ã€ããŠãèªç±ã§éãããè°è«ãšè©äŸ¡ãè¡ãããš ããéèŠã ãšèããã
çäºäŒã¯ãããã«ããŒãã ãŒã³ãã³ãŒã«ããœãŒãããã®çºè¡šã«å ããå°åºã®ã¹ã¿ããå»åž«ã§ããããªãŒã»ãžã£ã³ã»ã³å»åž«ããã話ãèããã
ãæçµçã«ã¯ãCOVID-19ã«ãããªã¹ã¯ãšæ¯èŒããŠãå®å
šæ§ãšæå¹æ§ã®æ¬ åŠãæããã«ç€ºã蚌æ ãããã圌ãïŒçäºäŒã¡ã³ããŒïŒã®æ±ºå®ã¯ãããåæ ãããã®ã§ãã£ãã
é£éŠä¿å¥æ©é¢ã®å§åã«çã£åããå察ããŠãã蚌æ ã«åºã¥ã㊠ãããããã®ã§ãããããªãã«ã¯èšã£ãïŒ
ãç§ãã¡ã®ä»åã®è¡åã¯ãä»ã®ä¿å¥æ©é¢ãè
æããé£éŠã·ã¹ãã ããå¥åº·ãšèªç±ãåãæ»ãããã®æš¡ç¯ã§ãããå
äŸã«ãªããšä¿¡ããŠããŸãããã®ããšããä»ã®ä¿å¥æ©é¢ããã®åé¡ããªãŒãã³ã«è°è«ããèªããšããã³ã¹ãè©äŸ¡ãããã£ããã«ãªãããšãé¡ã£ãŠãããã
ããããçå®ã®çŒ¶è©°ãéããæ¹æ³ã ã
ã«ãŒã«ãã§ã«ãæ°ã¯ããã®çäºäŒã®ç»æçãªæ±ºå®ããã¢ã€ããå·ãå šç±³ã®ä»ã®å»ç管çè ã«åæ§ã®åããä¿ãããšã«ãªããšç¢ºä¿¡ããŠãããšèªã£ãã
ããã¬ã€æ°ãããã«åæãããããã¬ã€æ°ã¯ãå西å°åºã®æç¥šãç¥ã£ãã¢ã€ããå·ã®ä»ã®2ã€ã®ä¿å¥å°åºããCOVID-19ã®äºé²æ³šå°ã®äžæ¢ãæ€èšããŠããããšããã§ã«èãããšèªã£ãã
ããã¬ã€ã¯ä»ã®ç±³åœåžæ°ã«ããå°å ã®ä¿å¥å§å¡ã«é£çµ¡ãåããCOVID-19ã¯ã¯ãã³ã®å®å šæ§æ å ±ãèŠçŽãããæ±ããããå§ããã
é£éŠæ¿åºã®ä¿å¥æ©é¢ã®æå°è ã®å€ãã¯ç£æ¥çã«åã蟌ãŸããŠããããå°æ¹ã¬ãã«ã®ä¿å¥å§å¡ã¯ããã§ã¯ãªããšããã¬ã€ã¯èšããã圌ãã¯ãŸã è²·åãããŠããªãã®ã§ãã
ãããªãã«å士ãã³ãŒã«å士ãããã«ããŒå士ãã ãŒã³å士ãã¹ã³ãŒãå士ã®ãããªå°å ã®å»åž«ãã¡ãé£ããŠããŠçºè¡šãããã°ãããã¯å ¬ã®èšé²ãšãªããå°å瀟äŒã¯ãããç¥ãããšã«ãªããŸãã
ããããçå®ã®çŒ¶è©°ãéããæ¹æ³ã§ãããšããã¬ã€ã¯ä»ãå ããã
CDCïŒç±³åœçŸç äºé²ç®¡çã»ã³ã¿ãŒïŒã¯COVID-19ã¯ã¯ãã³ãæšå¥šããFDAïŒç±³åœé£åå»è¬åå±ïŒã¯ãããæ¿èªããŠããããäžè¬çã«ãããæšé²ããæ¿çãæ¡çšããã®ã¯å°å ã®æ©é¢ã§ããã
ãã©ã³ãã¯èšãããæ²ããããšã«ã人ã ã¯èªåãã¡ã®å¥åº·ã«é¢ããŠã¯ãé£éŠæ¿åºãããä¿¡çšã§ããªããšããããšãåãå ¥ããå¿ èŠãããã
VAERSïŒCOVIDã¯ã¯ãã³æ¥çš®åŸã«160äžä»¶ã®å·å®³ãŸãã¯æ»äº¡ã®å ±å
ããã«ããŒè²¡å£ã®ç«åŠè ãã³ã©ã¹ã»ãã«ã·ã£ãŒã¯ãçäºäŒã®è¡åãè³è³ããã
ããµãŠã¹ãŠãšã¹ãã»ã¢ã€ããä¿å¥å°åºã¯ãCOVID-19泚å°ã蚺çæããæ€å»ãããšãããæ£ãã忢ãªéžæãããŸããããæŽæ°ãããããŒã¹ã¿ãŒã¯äººäœå®éšãããããšããªãã
ãã«ã·ã£ãŒæ°ã¯ããã€ãžãŒå·ç«å ¬å ±ã©ãžãªããããã«ããŒæ°ãã®çºè¡šã ãåã¯ã¯ãã³ ãã§ãããšå ±éããããšãææããã
ãã€ãžãŒå·ç«å ¬å ±ã©ãžãªã®èšäºã¯ãããã«ããŒãšä»ã®çºè¡šè ã ãé°è¬è«ã誀ã£ãæ å ±ãåºããããšã§åºãéé£ãããŠããå»åž« ããšåŒã³ããCOVID-19ã¯ã¯ãã³ãç²ç®çã«æ¯æããäžæ¹ã§æ·±ãææ ®ãã¹ãå®å šæ§ããŒã¿ãç¡èŠããŠãã ãããã«èŠããããšåœŒã¯è¿°ã¹ãã
äŸãã°ãCOVID-19ã¯ã¯ãã³æ¥çš®åŸã« Vaccine Adverse Event Reporting SystemïŒVAERSïŒã«å ±åãããå·å®³ãæ»äº¡ã®æ°ã¯å¢å ã®äžéããã©ã£ãŠããã
VAERSã¯ãç±³åœã«ãããã¯ã¯ãã³æå®³äºè±¡å ±åã®äž»èŠãªã¡ã«ããºã ã§ãããVAERSã«æåºãããå ±åã¯ãå ±åãããæå®³äºè±¡ãã¯ã¯ãã³ã«ãã£ãŠåŒãèµ·ãããããã®ã§ããããšã確èªããåã«ããããªã調æ»ãå¿ èŠãšãããVAERSã¯æŽå²çã«ã å®éã®ã¯ã¯ãã³æå®³äºè±¡ã®ããã 1ïŒ ããå ±åããªãããšã瀺ãããŠããã
9æ27æ¥çŸåšãCOVID-19ã¯ã¯ãã³æ¥çš®åŸã®å·å®³ãŸãã¯æ»äº¡ã«é¢ããVAERSå ±åã¯1,604,710ä»¶ããã
çäºäŒã®æ¡æ±ºã¯ãCOVID-19ã®äºé²æ¥çš®ããå€§èŠæš¡ãªå·å®³ãããããéºäŒåæ²»ç補åã§ããããšããäžè¬åžæ°ã®èªèãé«ããã®ã«åœ¹ç«ã£ãŠããããšãã©ã³ãã¯è¿°ã¹ãã
ããªãã«ãåæèŠã§ããïŒ
ããããã®äºé²æ³šå°ã¯ãåŸæ¥ã®å®çŸ©ã§ã¯ã¯ã¯ãã³ã§ã¯ãªãããšãçè§£ããŠãããå¿ èŠããããŸããã€ãŸããå ç«ãä»äžãããã®ã§ããªããã°ãææãé²ããã®ã§ããªãã
ãæ¿åºãã¡ãã£ã¢ã«ãã£ãŠæµåžãããæ ¹æ ã®ãªãææãèæ¯ã«ãæ³çå 責ãäžãããã匷å¶çã«äžçã®äººã ã«æŒãä»ããããã®ã§ããã
ããã«ãæã ãæã£ãŠããå®å šæ§ãšæå¹æ§ã®ããŒã¿ã¯éãããŠãããäž»ã«ãããã®æ³šå°ã§äœååãã«ãå²ããããšããŠããã¯ã¯ãã³äŒç€Ÿãçºè¡šãããã®ã§ããããšããªãã«ã¯ä»ãå ããã
ããã®COVID-19ã®mRNAéºäŒåæ²»çã®å®éšã¯ãäžçå²äžæãæªè³ªãªå€§é殺æ®ã®äžäŸã§ããããšãæããã«ãªãã§ãããã